Tandem Diabetes Care (TNDM) Invested Capital (2013 - 2026)
Tandem Diabetes Care posted quarterly Invested Capital of $132.4 million for Q1 2026, down 32.46% year-on-year from $196.0 million in Q1 2025, and down 14.67% on a QoQ basis from $155.2 million in Q4 2025.
Tandem Diabetes Care (TNDM) has 14 years of Invested Capital data on file, last reported at $132.4 million in Q1 2026.
- For the quarter ending Q1 2026, Invested Capital fell 32.46% year-over-year to $132.4 million; the trailing twelve-month figure through Mar 2026 stood at $132.4 million (down 32.46% YoY), and the FY2025 full-year result was $155.2 million, down 48.92% from the prior year.
- Invested Capital for Q1 2026 stood at $132.4 million, down from $155.2 million in the prior quarter.
- Across five years, Invested Capital topped out at $449.6 million in Q2 2022 and bottomed at $132.4 million in Q1 2026.
- The 5-year median for Invested Capital is $303.8 million (2024), against an average of $287.9 million.
- The widest annual swing landed in 2022, when Invested Capital soared 39.55%; it then slumped 52.22% in 2025.
- A 5-year view of Invested Capital shows it stood at $439.9 million in 2022, then dropped by 28.71% to $313.6 million in 2023, then decreased by 3.15% to $303.8 million in 2024, then plunged by 48.92% to $155.2 million in 2025, then retreated by 14.67% to $132.4 million in 2026.
- The last three Invested Capital figures came in at $132.4 million (Q1 2026), $155.2 million (Q4 2025), and $133.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 86.11 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 23.48 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 49.39 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 26.45 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.96 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 20.80 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 9.01 Bn |
| 10 | Tandem Diabetes Care | 1.31 Bn | 739.55 Mn | 136.79 Mn | 132.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 132.40 Mn |
| Dec 31, 2025 | 155.17 Mn |
| Sep 30, 2025 | 132.97 Mn |
| Jun 30, 2025 | 133.28 Mn |
| Mar 31, 2025 | 196.03 Mn |
| Dec 31, 2024 | 303.77 Mn |
| Sep 30, 2024 | 278.32 Mn |
| Jun 30, 2024 | 274.42 Mn |
| Mar 31, 2024 | 243.06 Mn |
| Dec 31, 2023 | 313.63 Mn |
| Sep 30, 2023 | 314.00 Mn |
| Jun 30, 2023 | 329.23 Mn |
| Mar 31, 2023 | 338.75 Mn |
| Dec 31, 2022 | 439.95 Mn |
| Sep 30, 2022 | 421.82 Mn |
| Jun 30, 2022 | 449.58 Mn |
| Mar 31, 2022 | 437.38 Mn |
| Dec 31, 2021 | 433.11 Mn |
| Sep 30, 2021 | 389.65 Mn |
| Jun 30, 2021 | 346.09 Mn |
| Mar 31, 2021 | 313.41 Mn |
| Dec 31, 2020 | 366.31 Mn |
| Sep 30, 2020 | 326.54 Mn |
| Jun 30, 2020 | 267.70 Mn |
| Mar 31, 2020 | 207.18 Mn |
| Dec 31, 2019 | 194.98 Mn |
| Sep 30, 2019 | 166.99 Mn |
| Jun 30, 2019 | 145.35 Mn |
| Mar 31, 2019 | 120.96 Mn |
| Dec 31, 2018 | 131.28 Mn |
| Sep 30, 2018 | 115.43 Mn |
| Jun 30, 2018 | 26.00 Mn |
| Mar 31, 2018 | 11.85 Mn |
| Dec 31, 2017 | -29.15 Mn |
| Sep 30, 2017 | -27.96 Mn |
| Jun 30, 2017 | -18.28 Mn |
| Mar 31, 2017 | -1.87 Mn |
| Dec 31, 2016 | -5.93 Mn |
| Sep 30, 2016 | 5.20 Mn |
| Jun 30, 2016 | 32.07 Mn |
| Mar 31, 2016 | 45.94 Mn |
| Dec 31, 2015 | 63.47 Mn |
| Sep 30, 2015 | 71.23 Mn |
| Jun 30, 2015 | 87.75 Mn |
| Mar 31, 2015 | 102.25 Mn |
| Dec 31, 2014 | 54.57 Mn |
| Sep 30, 2014 | 67.48 Mn |
| Jun 30, 2014 | 83.55 Mn |
| Mar 31, 2014 | 97.26 Mn |
| Dec 31, 2013 | 115.54 Mn |